Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-κB activation in vascular smooth muscle cells

Hypertension Research

Volumn 23, Issue 6, 2000, Pages 659-667

  Doi, M ^a   Shichiri, M ^a   Katsuyama, K ^a   Marumo, F ^a   Hirata, Y ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Inducible nitric oxide sythase; NF B cytokine; P42 p44 MAP kinase; Vascular smooth muscle cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; COMPLEMENTARY DNA; CYTOKINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 1BETA; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MONOCLONAL ANTIBODY; NITRATE; NITRATE REDUCTASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; POLYCLONAL ANTIBODY; PROTEIN ANTIBODY; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HYPERTENSION; IMMUNOREGULATION; MALE; NONHUMAN; PATHOGENESIS; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSACTIVATION; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 0034529810     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.23.659     Document Type: Article

References (38)

1. Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease
2. Endothelial nitric oxide synthase expression and its functionality
3. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells
4. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP
5. Salt-induced hypertension in Dahl salt-resistant and salt-sensitive rats with NOS II inhibition
6. Role of nitric oxide in the evolution of renal ischemia in two-kidney, one-clip renovascular hypertension
7. Alterations of nitric oxide synthase expression with aging and hypertension in rats
8. Nuclear factor-χB: A pivotal transcription factor in chronic inflammatory diseases
9. Role of nuclear factor-κB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells
10. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells
11. NO inhibits cytokine-induced iNOS expression and NF-κB activation by interfering with phosphorylation and degradation of IκB-α
12. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation
13. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
14. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
15. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures
16. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes
17. Role of interferon regulatory factor-1 and mitogen-activated protein kinase pathways in the induction of nitric oxide synthase-2 in retinal pigmented epithelial cells
18. Constitutive mutant and putative regulatory serine phosphorylation site of mammalian MAP kinase kinase (MEK1)
19. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells
20. Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transferrin
21. Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells
22. Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway
23. The LightCycler: A microvolume multisample fluorimeter with rapid temperature control
24. Induction of max by adrenomedullin and CGRP antagonizes endothelial apoptosis
25. Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon γ and lipopolysaccharide
26. SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes
27. Role of PKC and tyrosine kinase in ethanol-mediated inhibition of LPS-inducible nitric oxide synthase
28. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-γ due to phosphorylation of Stat1 and Stat3
29. 2 stimulates acute and chronic activation of the mitogen-activated protein kinase cascade in rat renal mesangial cells
30. Interleukin-1β regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes
31. Salicylate inhibition of extracellular signal-regulated kinases and inducible nitric oxide synthase
32. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide
33. Molecular cloning of the rat inducible nitric oxide synthase gene promoter
34. Nitric oxide synthase isotype expression in salt-sensitive and salt-resistant Dahl rats
35. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats
36. Characteristics of pressor response to endothelin in spontaneously hypertensive and Wistar-Kyoto rats
37. Differential pressor and renal vascular reactivity to angiotensin II in spontaneously hypertensive and Wistar-Kyoto rats
38. A cascade model for restenosis. A special case of atherosclerosis progression